Comparison of nine second-and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis

Nobuhide Hayashi, Shunichi Kumagai, Kenichiro Onuma, Kenichi Uto, Daisuke Sugiyama, Jun Saegusa, Seiji Kawano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The aim of this study was to compare the diagnostic and analytical performances of nine anti-cyclic citrullinated peptide (CCP) antibody assays. Anti-CCP antibody titers were measured in sera from 89 patients with rheumatoid arthritis (RA), 121 with rheumatic diseases other than RA (non-RA), 47 with osteoarthritis (OA), 142 with chronic inflammatory diseases (CID) and 168 healthy subjects. Reproducibility, sensitivity, specificity, correlation and concordance rate of the nine assays were compared. Coeficients of variations of within-run and between-run reproducibility at two different concentrations for each assay ranged from 0.7 to 8.5% and from 0.6 to 8.3%, respectively. With our proposed optimal cut-oFF value for the third-generation assay, concordance rates were 96.8~99.6%. The range of sensitivity was 75.3~78.7% and the ranges of specificity for non-RA, OA, CID, and healthy subjects were 93.4~97.5%, 97.9%, 96.5~98.6% and 98.8~100%, respectively. However, several discrepant samples were detected and their titer levels were about 3 times higher than the normal upper limit in the 2010 RA classification criteria. Good positive correlations were observed for parts of the second-generation assay. Our study showed that each of the nine assays has good reproducibility and high diagnostic accuracy, and is thus equally useful for the diagnosis of RA.

Original languageEnglish
Pages (from-to)104-114
Number of pages11
JournalJapanese Journal of Clinical Immunology
Volume36
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Rheumatoid Arthritis
Antibodies
Osteoarthritis
Arthritis
Healthy Volunteers
Chronic Disease
Rheumatic Diseases
Sensitivity and Specificity
cyclic citrullinated peptide
Serum

Keywords

  • Anti-cyclic citrullinated peptide antibodies
  • Rheumatoid arthritis
  • Rheumatoid factor
  • Second-generation
  • Third-generation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Comparison of nine second-and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis. / Hayashi, Nobuhide; Kumagai, Shunichi; Onuma, Kenichiro; Uto, Kenichi; Sugiyama, Daisuke; Saegusa, Jun; Kawano, Seiji.

In: Japanese Journal of Clinical Immunology, Vol. 36, No. 2, 2013, p. 104-114.

Research output: Contribution to journalArticle

Hayashi, Nobuhide ; Kumagai, Shunichi ; Onuma, Kenichiro ; Uto, Kenichi ; Sugiyama, Daisuke ; Saegusa, Jun ; Kawano, Seiji. / Comparison of nine second-and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis. In: Japanese Journal of Clinical Immunology. 2013 ; Vol. 36, No. 2. pp. 104-114.
@article{626aeed20ec74c5aa3ff1b296ccd626f,
title = "Comparison of nine second-and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis",
abstract = "The aim of this study was to compare the diagnostic and analytical performances of nine anti-cyclic citrullinated peptide (CCP) antibody assays. Anti-CCP antibody titers were measured in sera from 89 patients with rheumatoid arthritis (RA), 121 with rheumatic diseases other than RA (non-RA), 47 with osteoarthritis (OA), 142 with chronic inflammatory diseases (CID) and 168 healthy subjects. Reproducibility, sensitivity, specificity, correlation and concordance rate of the nine assays were compared. Coeficients of variations of within-run and between-run reproducibility at two different concentrations for each assay ranged from 0.7 to 8.5{\%} and from 0.6 to 8.3{\%}, respectively. With our proposed optimal cut-oFF value for the third-generation assay, concordance rates were 96.8~99.6{\%}. The range of sensitivity was 75.3~78.7{\%} and the ranges of specificity for non-RA, OA, CID, and healthy subjects were 93.4~97.5{\%}, 97.9{\%}, 96.5~98.6{\%} and 98.8~100{\%}, respectively. However, several discrepant samples were detected and their titer levels were about 3 times higher than the normal upper limit in the 2010 RA classification criteria. Good positive correlations were observed for parts of the second-generation assay. Our study showed that each of the nine assays has good reproducibility and high diagnostic accuracy, and is thus equally useful for the diagnosis of RA.",
keywords = "Anti-cyclic citrullinated peptide antibodies, Rheumatoid arthritis, Rheumatoid factor, Second-generation, Third-generation",
author = "Nobuhide Hayashi and Shunichi Kumagai and Kenichiro Onuma and Kenichi Uto and Daisuke Sugiyama and Jun Saegusa and Seiji Kawano",
year = "2013",
doi = "10.2177/jsci.36.104",
language = "English",
volume = "36",
pages = "104--114",
journal = "Immunological Medicine",
issn = "0911-4300",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Comparison of nine second-and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis

AU - Hayashi, Nobuhide

AU - Kumagai, Shunichi

AU - Onuma, Kenichiro

AU - Uto, Kenichi

AU - Sugiyama, Daisuke

AU - Saegusa, Jun

AU - Kawano, Seiji

PY - 2013

Y1 - 2013

N2 - The aim of this study was to compare the diagnostic and analytical performances of nine anti-cyclic citrullinated peptide (CCP) antibody assays. Anti-CCP antibody titers were measured in sera from 89 patients with rheumatoid arthritis (RA), 121 with rheumatic diseases other than RA (non-RA), 47 with osteoarthritis (OA), 142 with chronic inflammatory diseases (CID) and 168 healthy subjects. Reproducibility, sensitivity, specificity, correlation and concordance rate of the nine assays were compared. Coeficients of variations of within-run and between-run reproducibility at two different concentrations for each assay ranged from 0.7 to 8.5% and from 0.6 to 8.3%, respectively. With our proposed optimal cut-oFF value for the third-generation assay, concordance rates were 96.8~99.6%. The range of sensitivity was 75.3~78.7% and the ranges of specificity for non-RA, OA, CID, and healthy subjects were 93.4~97.5%, 97.9%, 96.5~98.6% and 98.8~100%, respectively. However, several discrepant samples were detected and their titer levels were about 3 times higher than the normal upper limit in the 2010 RA classification criteria. Good positive correlations were observed for parts of the second-generation assay. Our study showed that each of the nine assays has good reproducibility and high diagnostic accuracy, and is thus equally useful for the diagnosis of RA.

AB - The aim of this study was to compare the diagnostic and analytical performances of nine anti-cyclic citrullinated peptide (CCP) antibody assays. Anti-CCP antibody titers were measured in sera from 89 patients with rheumatoid arthritis (RA), 121 with rheumatic diseases other than RA (non-RA), 47 with osteoarthritis (OA), 142 with chronic inflammatory diseases (CID) and 168 healthy subjects. Reproducibility, sensitivity, specificity, correlation and concordance rate of the nine assays were compared. Coeficients of variations of within-run and between-run reproducibility at two different concentrations for each assay ranged from 0.7 to 8.5% and from 0.6 to 8.3%, respectively. With our proposed optimal cut-oFF value for the third-generation assay, concordance rates were 96.8~99.6%. The range of sensitivity was 75.3~78.7% and the ranges of specificity for non-RA, OA, CID, and healthy subjects were 93.4~97.5%, 97.9%, 96.5~98.6% and 98.8~100%, respectively. However, several discrepant samples were detected and their titer levels were about 3 times higher than the normal upper limit in the 2010 RA classification criteria. Good positive correlations were observed for parts of the second-generation assay. Our study showed that each of the nine assays has good reproducibility and high diagnostic accuracy, and is thus equally useful for the diagnosis of RA.

KW - Anti-cyclic citrullinated peptide antibodies

KW - Rheumatoid arthritis

KW - Rheumatoid factor

KW - Second-generation

KW - Third-generation

UR - http://www.scopus.com/inward/record.url?scp=84922687289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922687289&partnerID=8YFLogxK

U2 - 10.2177/jsci.36.104

DO - 10.2177/jsci.36.104

M3 - Article

AN - SCOPUS:84922687289

VL - 36

SP - 104

EP - 114

JO - Immunological Medicine

JF - Immunological Medicine

SN - 0911-4300

IS - 2

ER -